Dyer Timothy Mark 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-05 4:00 pm Unchanged |
2023-04-04 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 492,766 11.090% |
0 (Unchanged) |
Filing |
| 2023-03-31 4:00 pm Unchanged |
2023-03-30 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 492,766 12.180% |
0 (Unchanged) |
Filing |
| 2022-11-23 06:00 am Unchanged |
2022-11-14 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 492,766 13.540% |
0 (Unchanged) |
Filing |
| 2022-11-09 4:00 pm Purchase |
2022-10-26 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 492,766 20.010% |
269,741 (+120.95%) |
Filing |
| 2022-08-05 06:01 am Purchase |
2022-07-26 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 223,025 8.400% |
41,476 (+22.85%) |
Filing |
| 2021-09-08 06:01 am Purchase |
2021-08-30 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 181,549 9.730% |
38,172 (+26.62%) |
Filing |
| 2020-11-03 4:10 pm Purchase |
2020-10-25 | 13D | Addex Therapeutics Ltd ADXN |
Dyer Timothy Mark | 143,377 8.730% |
143,377 (New Position) |
Filing |